Molecular Characterization of Clinical Isolates of Human Immunodeficiency Virus Resistant to the Protease Inhibitor Darunavir

Documenti analoghi

• Ninety-Nine Is Not Enough: Molecular Characterization of Inhibitor-Resistant Human Immunodeficiency Virus Type 1 Protease Mutants with Insertions in the Flap Region
  di: Kožíšek, Milan, et al.
  Pubblicazione: (2008)
• GS-8374, a Prototype Phosphonate-Containing Inhibitor of HIV-1 Protease, Effectively Inhibits Protease Mutants with Amino Acid Insertions
  di: Grantz Šašková, Klára, et al.
  Pubblicazione: (2014)
• Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir
  di: Šašková, Klára Grantz, et al.
  Pubblicazione: (2008)
• Mutations in HIV-1 gag and pol Compensate for the Loss of Viral Fitness Caused by a Highly Mutated Protease
  di: Kožíšek, Milan, et al.
  Pubblicazione: (2012)
• From nonpeptide toward noncarbon protease inhibitors: Metallacarboranes as specific and potent inhibitors of HIV protease
  di: Cígler, Petr, et al.
  Pubblicazione: (2005)